Two Sigma Investments’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.4M Buy
2,276,574
+283,669
+14% +$2.66M 0.04% 513
2025
Q1
$14.2M Buy
1,992,905
+149,162
+8% +$1.06M 0.03% 601
2024
Q4
$21.5M Buy
1,843,743
+863,363
+88% +$10.1M 0.05% 427
2024
Q3
$20.1M Buy
980,380
+151,095
+18% +$3.11M 0.04% 458
2024
Q2
$18.6M Buy
829,285
+214,717
+35% +$4.81M 0.04% 459
2024
Q1
$16.9M Buy
614,568
+106,681
+21% +$2.93M 0.04% 458
2023
Q4
$15.5M Buy
507,887
+343,897
+210% +$10.5M 0.04% 467
2023
Q3
$5.19M Buy
163,990
+121,090
+282% +$3.83M 0.01% 839
2023
Q2
$1.75M Sell
42,900
-97,258
-69% -$3.97M ﹤0.01% 1461
2023
Q1
$5.22M Sell
140,158
-60,256
-30% -$2.25M 0.01% 833
2022
Q4
$6.99M Buy
200,414
+108,819
+119% +$3.8M 0.02% 668
2022
Q3
$5.13M Sell
91,595
-328,908
-78% -$18.4M 0.02% 718
2022
Q2
$21.8M Sell
420,503
-57,750
-12% -$2.99M 0.07% 305
2022
Q1
$34.8M Buy
478,253
+280,092
+141% +$20.4M 0.1% 244
2021
Q4
$23.4M Sell
198,161
-111,993
-36% -$13.2M 0.05% 386
2021
Q3
$41.6M Buy
310,154
+263,312
+562% +$35.3M 0.09% 222
2021
Q2
$7.58M Sell
46,842
-299,862
-86% -$48.5M 0.02% 751
2021
Q1
$27.8M Buy
346,704
+62,566
+22% +$5.02M 0.07% 284
2020
Q4
$15.5M Buy
284,138
+35,118
+14% +$1.91M 0.04% 397
2020
Q3
$4.95M Sell
249,020
-22,994
-8% -$457K 0.02% 613
2020
Q2
$5.72M Buy
272,014
+112,820
+71% +$2.37M 0.03% 502
2020
Q1
$1.95M Sell
159,194
-124,293
-44% -$1.52M 0.02% 693
2019
Q4
$4.16M Buy
283,487
+195,233
+221% +$2.86M 0.01% 809
2019
Q3
$1.18M Sell
88,254
-24,567
-22% -$328K ﹤0.01% 1136
2019
Q2
$1.85M Buy
+112,821
New +$1.85M 0.01% 1112
2019
Q1
Sell
-148,261
Closed -$2.02M 2360
2018
Q4
$2.02M Buy
+148,261
New +$2.02M 0.01% 1038